Comparison of Analgesic Effect of 0.4 mg versus 0.8 mg Intrathecal Nalbuphine as an Adjuvant to 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries: A Randomized Double-Blind Study
International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)
DOI: 10.25258/ijcpr.18.4.154 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Sandeep Kumar Sharma und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Intrathecal adjuvants are widely used to enhance the quality and duration of spinal anaesthesia. Nalbuphine, a mixed opioid agonist-antagonist, has shown promising results in improving postoperative analgesia with minimal side effects.
Objective
To compare the analgesic efficacy of intrathecal nalbuphine 0.4 mg versus 0.8 mg as an adjuvant to 0.5% hyperbaric bupivacaine in lower abdominal surgeries.
Methods
This randomized double-blind interventional study included 60 patients (ASA I–II) undergoing elective lower abdominal surgeries. Patients were divided into two groups (n=30 each): Group A received 0.4 mg nalbuphine and Group B received 0.8 mg nalbuphine with 0.5% hyperbaric bupivacaine intrathecally. Parameters assessed included onset and duration of sensory and motor block, duration of analgesia, Visual Analog Scale (VAS), hemodynamic variables, and adverse effects.
Results
Demographic parameters were comparable between groups. Onset of sensory and motor block showed no significant difference (p>0.05). However, duration of analgesia was significantly prolonged in Group B (278.03 ± 7.48 min) compared to Group A (236.83 ± 9.84 min) (p
Zitieren
APA
Sharma, S. K., Rajbala, R., & Kanwar, S. (2026). Comparison of Analgesic Effect of 0.4 mg versus 0.8 mg Intrathecal Nalbuphine as an Adjuvant to 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries: A Randomized Double-Blind Study. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.154
Vancouver
Sharma SK, Rajbala R, Kanwar S. Comparison of Analgesic Effect of 0.4 mg versus 0.8 mg Intrathecal Nalbuphine as an Adjuvant to 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries: A Randomized Double-Blind Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.154
BibTeX
@article{Sharma2026,
author = {Sharma, Sandeep Kumar and Rajbala, Rajbala and Kanwar, Santosh},
title = {Comparison of Analgesic Effect of 0.4 mg versus 0.8 mg Intrathecal Nalbuphine as an Adjuvant to 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries: A Randomized Double-Blind Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {04},
doi = {10.25258/ijcpr.18.4.154}
}
EUVIMED